Clarity in cell line development

Removal of fluorescence screening of clones in cell line development: a paradigm shift

Dr Ian Taylor, Chief Commercial Officer, Solentim, blogs on his views following the recent ESACT conference in Copenhagen. Having just returned from ESACT in Copenhagen, I was impressed once again with the extremely high quality of the poster sessions throughout the event, presented by top level scientists working in labs around the world. One aspect …

Read more Removal of fluorescence screening of clones in cell line development: a paradigm shift

Solentim will be exhibiting at Hanson Wades’s 5th Precision CRISPR Genome Editing Congress in Boston

Solentim, a global leader in cell line development instrumentation is pleased to announce it will be attending and exhibiting at the 5th Precision CRISPR Genome Editing Congress, 21st-23rd May, in Boston, USA The conference will focus on the delivery of more precise, efficient and safer genome editing to optimise drug discovery, functional screening and CRISPR-based cell …

Read more Solentim will be exhibiting at Hanson Wades’s 5th Precision CRISPR Genome Editing Congress in Boston

Solentim, along with collaborator Janssen, will be speaking and exhibiting at the 8th Annual Cell Line Development and Engineering Asia Conference

Solentim, a global leader in cell line development instrumentation, will be speaking and exhibiting at the 8thAnnual Cell Line Development and Engineering Asia conference, 14th-16thMay 2019, in Shanghai. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth (#14) to discuss our latest innovations and to answer any questions. …

Read more Solentim, along with collaborator Janssen, will be speaking and exhibiting at the 8th Annual Cell Line Development and Engineering Asia Conference

Solentim and SAL Scientific announce partnership for novel growth supplements in cell line development

Solentim, the global leader in cell line development (CLD) imaging instrumentation, and SAL Scientific, a leading provider of growth enhancing animal-free cell culture reagents, are pleased to announce a new strategic partnership. The collaboration will further optimise CLD workflow by supplying novel supplements which substantially improve cell growth. Solentim will act as the exclusive distributor for …

Read more Solentim and SAL Scientific announce partnership for novel growth supplements in cell line development

Conference News Item: Solentim presenting two posters at ESACT 2019

Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be attending the 26th ESACT Meeting, 5th – 8th May 2019 in Copenhagen, Denmark. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth to discuss our latest products and collaborations. The theme of …

Read more Conference News Item: Solentim presenting two posters at ESACT 2019

Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources Solentim and Valitacell announce a total of €3.5m funding to produce an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving …

Read more Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies